SCD and osteoporosis: We believe that by converting harmful saturated fatty acids to beneficial monounsaturated fatty acids, as demonstrated by SCD1 overexpression, this approach could provide a foundation for future osteoporosis treatments that not only prevent bone loss but also promote bone regeneration.